Immuron Limited - Warrants (12/05/2022) Profit Margin

The latest profit margin for IMRNW is -62.57% as of December 2025. That compares with -114.11% in the prior-year period — up 45.2% year over year. That is below the Healthcare sector average of 13.89%. Investors often review this figure alongside Immuron Limited - Warrants (12/05/2022)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, IMRNW's profit margin moved from -114.11% to -62.57% — a 45.2% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Immuron Limited - Warrants (12/05/2022)'s valuation or profitability profile.

Against Healthcare companies, IMRNW currently prints -62.57% for profit margin, while the sector average sits near 13.89%. That is roughly 550.4% below the sector mean. Large gaps often invite a closer look at Immuron Limited - Warrants (12/05/2022)'s growth, margins, and balance sheet.

Profit Margin shows how effectively Immuron Limited - Warrants (12/05/2022) converts resources into returns. At -62.57%, IMRNW may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -114.11% in the prior-year period — up 45.2% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting IMRNW's profit margin (-62.57%), review year-over-year change from -114.11%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.